ICAD Inc reports results for the quarter ended September 30 - Earnings Summary

• ICAD Inc ICAD.OQ reported a quarterly adjusted loss of 7 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of three analysts for the quarter was for a loss of 8 cents per share. Wall Street expected results to range from -9 cents to -8 cents per share.

• Revenue rose 3.5% to $4.22 million from a year ago; analysts expected $4.52 million.

• ICAD Inc's reported EPS for the quarter was a loss of 7 cents​.

• The company reported a quarterly loss of $1.8 million.

• ICAD Inc shares had risen by 53.4% this quarter and gained 35.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for ICAD Inc is 3.00

This summary was machine generated from LSEG data November 14 at 04:03 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)